|
TRGT - deal/@ $40-share takeover expected - hearing that TRGT has multiple partnership offers for TC-4214 in the $200 million up front range it might start a bidding war for the whole company in the $40 range. Glaxo and Astra Zeneca most likely buyers
Sentiment : Strong Buy Rating :
 (1 Rating) |
36/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.69